For the quarter ending 2026-03-31, DRIO made $5,584K in revenue. -$8,249K in net income. Net profit margin of -147.73%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenues | 5,584 | 5,231 | 5,007 | 5,369 |
| Service | 563 | 601 | 613 | 821 |
| Hardware And Consumable Products | 1,644 | 1,645 | 1,198 | 1,151 |
| Amortization Of Acquired Intangible Assets | 177 | 181 | 181 | 433 |
| Total cost of revenues | 2,384 | 2,427 | 1,992 | 2,405 |
| Gross profit | 3,200 | 2,804 | 3,015 | 2,964 |
| Research and development | 2,385 | 2,634 | 3,328 | 3,721 |
| Sales and marketing | 4,898 | 4,630 | 4,604 | 5,231 |
| General and administrative | 3,226 | 4,102 | 4,567 | 3,212 |
| Total operating expenses | 10,509 | 11,366 | 12,499 | 12,164 |
| Operating loss | -7,309 | -8,562 | -9,484 | -9,200 |
| Interest expenses | 1,149 | -451* | 1,157 | - |
| Other financial income, net | 266 | -837* | 175 | - |
| Total financial expenses (income), net | -883 | -386 | -982 | -3,790 |
| Loss before taxes | -8,192 | -8,948 | -10,466 | -12,990 |
| Income tax (benefit) | 57 | 83 | - | - |
| Net loss | -8,249 | -9,031 | -10,466 | -12,990 |
| Deemed dividend (contribution) | - | 1,221 | 8,389 | 5,572 |
| Net loss attributable to common shareholders | -8,249 | -10,252 | -18,855 | -18,562 |
| Basic EPS | 1.25 | -2.574 | 2.96 | 0.18 |
| Diluted EPS | 1.25 | -2.574 | 2.96 | 0.18 |
| Basic Average Shares | 6,582,297 | 3,982,956* | 3,138,106 | 49,630,949 |
| Diluted Average Shares | 6,582,297 | 3,982,956* | 3,138,106 | 49,630,949 |
DarioHealth Corp. (DRIO)
DarioHealth Corp. (DRIO)